Results 161 to 170 of about 491,575 (216)

Functional and multimodal approach to sarcopenia in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

Int J Colorectal Dis
Demirli Atici S, Canda AE, Terzi MC.
europepmc   +1 more source

Effects of argipressin on intraoperative fluid administration in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): study protocol of a randomised clinical trial (HiPress Trial). [PDF]

BMJ Open
van Zwol J, Aalbers AGJ, van den Brom CE, Hollmann MW, Hulst AH, Lameris W, Tuinman PR, Vlaar APJ, Veelo DP, Hemmes SNT.   +9 more
europepmc   +1 more source

Propensity score-matched evaluation of prophylactic hyperthermic intraperitoneal chemotherapy in geriatric patients with locally advanced colorectal cancer: safety and survival benefits. [PDF]

BMC Cancer
Yang M, Yang S, Zhang W, Ma F, Yu T.
europepmc   +1 more source

Inflammatory Markers may Determine Postoperative Complications in Cases of Peritoneal Carcinomatosis of Ovarian Origin Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. [PDF]

J Surg Oncol
Mustafa D, Tayfun B, Berke M, Selman S, Ecem SB, Nilay B, Sevda OO.   +6 more
europepmc   +1 more source

The Effect of Induced Hypothermia on Postoperative Outcomes Following Hyperthermic Intraperitoneal Chemotherapy: A Negative Finding. [PDF]

Ther Clin Risk Manag
Yang MC, Lin KL, Chung KC, Chou SE, Chien M, Hsu CY.   +5 more
europepmc   +1 more source

Expanding the role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study on uncommon peritoneal malignancies. [PDF]

World J Clin Oncol
Framarini M, D'Acapito F, Lippolis PV, Di Giorgio A, Di Pietrantonio D, Sommariva A, Sammartino P.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Annals of Surgical Oncology, 2023
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment modality that aims to target the main site of tumor dissemination in ovarian cancer, the peritoneum, by combining the benefits of intraperitoneal chemotherapy with the synergistic effects of hyperthermia all during a single administration at the time of cytoreductive surgery. High-quality
Julia H, Gelissen, Naomi N, Adjei, Blair, McNamara, Levent, Mutlu, Justin A, Harold, Mitchell, Clark, Gary, Altwerger, Peter R, Dottino, Gloria S, Huang, Alessandro D, Santin, Masoud, Azodi, Elena, Ratner, Peter E, Schwartz, Vaagn, Andikyan   +13 more
openaire   +2 more sources

Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy

Surgical Clinics of North America, 2020
Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy is an aggressive, potentially curative approach used to treat locoregional disease associated with primary and secondary malignancies of the peritoneum. It involves resection of all macroscopic disease larger than 2.5 mm, followed by instillation of hyperthermic chemotherapy ...
Eric, Pletcher, Elizabeth, Gleeson, Daniel, Labow   +2 more
openaire   +2 more sources